Showing 3,361 - 3,380 results of 4,194 for search 'SunCET~', query time: 2.64s Refine Results
  1. 3361

    Cancer stem cells and tumor-associated macrophages as mates in tumor progression: mechanisms of crosstalk and advanced bioinformatic tools to dissect their phenotypes and interacti... by Francesco Verona, Sebastiano Di Bella, Roberto Schirano, Camilla Manfredi, Francesca Angeloro, Giulia Bozzari, Matilde Todaro, Matilde Todaro, Giuseppe Giannini, Giuseppe Giannini, Giorgio Stassi, Veronica Veschi

    Published 2025-02-01
    “…Cancer stem cells (CSCs) are a small subset within the tumor mass significantly contributing to cancer progression through dysregulation of various oncogenic pathways, driving tumor growth, chemoresistance and metastasis formation. …”
    Get full text
    Article
  2. 3362

    A KSHV RNA-binding protein promotes FOS to inhibit nuclease AEN and transactivate RGS2 for AKT phosphorylation by Vladimir Majerciak, Beatriz Alvarado-Hernandez, Yanping Ma, Shivalee Duduskar, Alexei Lobanov, Maggie Cam, Zhi-Ming Zheng

    Published 2025-01-01
    “…Thus, KSHV lytic infection controls the expression of a subset of genes for signaling, cell cycle progression, and proliferation to potentially contribute to viral oncogenesis.…”
    Get full text
    Article
  3. 3363
  4. 3364

    Lung transplant outcomes for recipients with alpha-1 antitrypsin deficiency, by use of alpha-1 antitrypsin augmentation therapy by Atharv V. Oak, MEng, Jessica M. Ruck, MD, PhD, Alfred J. Casillan, MD, PhD, Armaan F. Akbar, BS, Ramon A. Riojas, MD, PhD, Pali D. Shah, MD, Jinny S. Ha, MD, MHS, Sara Strout, PharmD, Allan B. Massie, PhD, Dorry L. Segev, MD, PhD, Christian A. Merlo, MD, MPH, Errol L. Bush, MD

    Published 2025-02-01
    “…The ATE measures the observed effect we would see if everyone in the population received the intervention as opposed to just a subset. Results: Among the 447 recipients with AAT deficiency, 109 used AAT augmentation therapy pre-LT, of which 32 (29.4%) continued post-LT. …”
    Get full text
    Article
  5. 3365

    An atmospheric correction method for Himawari-8 imagery based on a multi-layer stacking algorithm by Menghui Wang, Donglin Fan, Hongchang He, You Zeng, Bolin Fu, Tianlong Liang, Xinyue Zhang, Wenhan Hu

    Published 2025-03-01
    “…Model evaluation and validation were performed using a test subset of simulated data and in-situ datasets. Validation results indicate that the MSM AC exhibits strong performance in the validation bands (470 nm, 510 nm, and 640 nm) on the in-situ dataset, with R2 values of 0.64, 0.91, and 0.82 and root-mean-square logarithmic deviation (RMSLD) values of 0.007 sr−1, 0.004 sr−1, and 0.005 sr−1, respectively. …”
    Get full text
    Article
  6. 3366

    Transcriptional signature of CD56bright NK cells predicts favourable prognosis in bladder cancer by Md Abdullah Al Kamran Khan, Alexander James Sedgwick, Yuhan Sun, Julian P. Vivian, Julian P. Vivian, Julian P. Vivian, Alexandra J. Corbett, Riccardo Dolcetti, Riccardo Dolcetti, Riccardo Dolcetti, Theo Mantamadiotis, Theo Mantamadiotis, Stefano Mangiola, Stefano Mangiola, Stefano Mangiola, Alexander David Barrow

    Published 2025-01-01
    “…Human natural killer (NK) cells can be sub-divided into two functional subsets but the clinical significance of these CD56bright and CD56dim NK cells in anti-tumour immunity remains largely unexplored. …”
    Get full text
    Article
  7. 3367

    Előszó by Kosztasz Rosta

    Published 2019-04-01
    “…A tematikus blokkot Gyöngyösi Megyer, Fazakas István és Forczek Ákos szerkesztette, közreműködéséért köszönet illeti Marosán Bencét, a konferencia szervezőjét. A játéktevékenység a fenomenológiai filozófia egyik kitüntetett témája, amennyiben az a világhoz való viszonyulásunk sajátos módozatait fedi fel. …”
    Get full text
    Article
  8. 3368

    Combining a WT1 Vaccine (Galinpepimut-S) With Checkpoint Inhibition (Nivolumab) in Patients With WT1–Expressing Diffuse Pleural Mesothelioma: A Phase 1 Study by Prashasti Agrawal, MD, Michael Offin, MD, Victoria Lai, MD, Michelle S. Ginsberg, MD, Prasad S. Adusumilli, MD, FACS, Valerie W. Rusch, MD, Jennifer L. Sauter, MD, Teresa Ho, BS, Phillip Wong, PhD, Marjorie G. Zauderer, MD

    Published 2025-01-01
    “…Conclusions: Coadministration of GPS and nivolumab reported a tolerable toxicity profile and induced immune responses in a subset of patients, but initial response and survival benefit were limited possibly owing to the small sample size.…”
    Get full text
    Article
  9. 3369

    Intrinsic subtype and immunity score in identification of triple-negative breast cancer at low risk by Xinyu Ren, Tong Zhou, Yu Song, Huanwen Wu, Jeff Chou, Lance D. Miller, Zhiyong Liang, Songjie Shen

    Published 2025-04-01
    “…Despite majority of them had the unfavorable prognosis, a subset of patients who do not receive chemotherapy exhibit a good prognosis. …”
    Get full text
    Article
  10. 3370

    Retrospective comparative survival analysis of ablation plus systemic therapy versus systemic therapy alone for breast cancer liver metastases, stratified by extrahepatic metastase... by Xuxiazi Zou, Hong-Liang Zou, Xuan Luo, Xu-Wei Chen, Wei-Ling Huang, Chao Zhang, Ge Ren, Jin-Hua Huang, Xue Han, Yi-Quan Jiang

    Published 2025-02-01
    “…After PSM, among patients with BCLM (≤3 tumors, each ≤3 cm), the median overall survival (OS) for those treated with AS or systemic therapy alone was 65.5 and 40.4 months, respectively (HR = 0.48, p = .003); in the subset of patients with extrahepatic metastases, the median OS for those treated with AS and systemic therapy alone was 46.4 and 40.8 months, respectively (HR = 0.58, p = .047). …”
    Get full text
    Article
  11. 3371

    Protein kinase inhibitors as targeted therapy for glioblastoma: a meta-analysis of randomized controlled clinical trials by José Pinto-Fraga, Celia García-Chico, Simone Lista, Pedro Miguel Lacal, Giuseppe Carpenzano, Maurizio Salvati, Alejandro Santos-Lozano, Grazia Graziani, Claudia Ceci

    Published 2025-02-01
    “…For instance, when comparing PKI treatment with other treatments, median OS and PFS showed no significant difference (-0.78 months, 95 % CI, −2.12–0.55, p = 0.25; −0.23 months, 95 % CI, −0.79–0.34, p = 0.43, respectively), and similar non-significant results were observed in the pooled analyses (OS: HR = 0.89, 95 % CI, 0.59–1.32, p = 0.55; PFS: HR = 0.83, 95 % CI, 0.63–1.11, p = 0.21).Despite these overall negative findings, some data indicate improved clinical outcomes in a subset of GBM patients treated with certain PKIs (i.e., regorafenib) and encourage further research to identify PKIs with better blood-brain barrier penetration and lower risk for resistance development.…”
    Get full text
    Article
  12. 3372
  13. 3373

    Effect of nonsteroidal anti-inflammatory drugs on neonatal calf diarrhea when administered at a disease alert generated by automated milk feeders by A. Welk, M.C. Cantor, H.W. Neave, J.H.C. Costa, J.L. Morrison, C.B. Winder, D.L. Renaud

    Published 2025-02-01
    “…Body weight was recorded at birth and weekly thereafter. A subset of calves (n = 32) were fitted with IceQube pedometers at 3 d of age to measure activity behaviors (lying time and step count). …”
    Get full text
    Article
  14. 3374
  15. 3375

    Deep cascaded registration and weakly-supervised segmentation of fetal brain MRI by Valentin Comte, Mireia Alenya, Andrea Urru, Judith Recober, Ayako Nakaki, Francesca Crovetto, Oscar Camara, Eduard Gratacós, Elisenda Eixarch, Fatima Crispi, Gemma Piella, Mario Ceresa, Miguel A. González Ballester

    Published 2025-01-01
    “…Furthermore, we integrate our registration method into a multi-atlas segmentation pipeline and showcase its competitive performance compared to nnU-Net, achieved using only a small subset of annotated images as atlases. This approach is particularly valuable in the context of fetal brain MRI, where annotated datasets are limited. …”
    Get full text
    Article
  16. 3376

    Cantelli’s Bounds for Generalized Tail Inequalities by Nicola Apollonio

    Published 2025-01-01
    “…Let <i>X</i> be a centered random vector in a finite-dimensional real inner product space <inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mi mathvariant="script">E</mi></semantics></math></inline-formula>. For a subset <i>C</i> of the ambient vector space <i>V</i> of <inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mi mathvariant="script">E</mi></semantics></math></inline-formula> and <inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mrow><mi>x</mi><mo>,</mo><mspace width="0.166667em"></mspace><mi>y</mi><mo>∈</mo><mi>V</mi></mrow></semantics></math></inline-formula>, write <inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mrow><mi>x</mi><msub><mo>⪯</mo><mi>C</mi></msub><mi>y</mi></mrow></semantics></math></inline-formula> if <inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mrow><mi>y</mi><mo>−</mo><mi>x</mi><mo>∈</mo><mi>C</mi></mrow></semantics></math></inline-formula>. …”
    Get full text
    Article
  17. 3377
  18. 3378

    Remote Sensing of Sun-Induced Fluorescence in a Deep Lake: Disentangling Quenching Mechanisms Improves Relationship With Chlorophyll-a Concentration Estimates by Remika S. Gupana, Daniel Odermatt, Abolfazl Irani Rahaghi, Camille Minaudo, Mortimer Werther, Claudia Giardino, Alexander Damm

    Published 2025-01-01
    “…It increases strongly when comparing PQ (<italic>R</italic><sup>2</sup> &#x003D; 0.72 and MAPD &#x003D; 49&#x0025;) and NPQ cases (<italic>R</italic><sup>2</sup> &#x003D; 0.48 and MAPD &#x003D; 68&#x0025;) separately. Analyzing a subset of in situ measurements acquired around Sentinel-3 overpasses (&PlusMinus;3 h) improved the performance metrics for both PQ (<italic>R</italic><sup>2</sup> &#x003D; 0.82 and MAPD &#x003D; 35&#x0025;) and NPQ cases (<italic>R</italic><sup>2</sup> &#x003D; 0.43 and MAPD &#x003D; 61&#x0025;). …”
    Get full text
    Article
  19. 3379
  20. 3380

    Serum metabolome indicators of early childhood development in the Brazilian National Survey on Child Nutrition (ENANI-2019) by Marina Padilha, Victor Nahuel Keller, Paula Normando, Raquel M Schincaglia, Nathalia C Freitas-Costa, Samary SR Freire, Felipe M Delpino, Inês RR de Castro, Elisa MA Lacerda, Dayana R Farias, Zachary Kroezen, Meera Shanmuganathan, Philip Britz-Mckibbin, Gilberto Kac

    Published 2025-01-01
    “…Methods: Untargeted metabolomics was performed on serum samples of 5004 children aged 6–59 months, a subset of participants from the Brazilian National Survey on Child Nutrition (ENANI-2019). …”
    Get full text
    Article